CD63 and cancer: As anti‐TNC antibody‐functionalized nanopillars enrich cancer‐associated sEVs, we expected DECODE to provide an sEV molecular profile with higher expressions of CD63, THBS2, VCAN, and TNC in the three lung cancer cell lines and low/negligible biomarker expression from HBECs and PBS controls.